Effects of HMG-CoA Reductase Inhibitors (Statins) On Bone Mineral Density and Metabolism
Hydroxy methylglutaryl coenzyme A reductase inhibitors (statins) have been shown to have effects on bone metabolism in laboratory studies. While early clinic studies have showed lower risk for osteoporotic fractures among statin users than nonusers, subsequent studies have found mixed results. The p...
Main Authors: | Nehir Samancı, M. Can Öksüz, Nilüfer Balcı, Mehmet Arman |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2004-06-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: | http://www.turkosteoporozdergisi.org/article_4197/Effects-Of-Hmg-coa-Reductase-Inhibitors-statins-On-Bone-Mineral-Density-And-Metabolism |
Similar Items
-
Bone Mineral Density in Stroke Patients
by: Nilüfer Balcı, et al.
Published: (2005-03-01) -
The Relationship of Statins Usage and Bone Mineral Density in Postmenopausal Women
by: Gholamreza Dashti, et al.
Published: (2014-06-01) -
Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01) -
Utilization of Statins, an HMG-CoA reductase inhibitors, in Ambon District Hospital, Maluku: a retrospective study
by: Abraham Simatupang, et al.
Published: (2018-10-01) -
The effects of one-year simvastatin therapy on women’s bone mineral density
by: Dimic Aleksandar, et al.
Published: (2011-02-01)